Sakine Nazik Bahcecioglu
Overview
Explore the profile of Sakine Nazik Bahcecioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vural Solak G, Aksu K, Solak Y, Demir S, Cuhadar Ercelebi D, Koycu Buhari G, et al.
Tuberk Toraks
. 2023 Dec;
71(4):356-366.
PMID: 38152006
Introduction: The aim of this study was to elucidate the incidence of local, large local and systemic reactions after subcutaneus immunotherapy (SCIT) injections in our clinic and to determine the...
2.
Yesilkaya S, Aksu K, Vural Solak G, Demir S, Topel M, Cuhadar Ercelebi D, et al.
J Oncol Pharm Pract
. 2023 Nov;
30(8):1358-1363.
PMID: 37936390
Aim: To present the characteristics of drug hypersensitivity reactions (DHRs) among taxane recipients with non-small cell lung carcinoma (NSCLC), and to describe the results of rapid drug desensitization (RDD). Methods:...
3.
Koycu Buhari G, Koca Kalkan I, Ates H, Nazik Bahcecioglu S, Demir S, Yesilkaya S, et al.
Allergol Immunopathol (Madr)
. 2023 Mar;
51(2):130-136.
PMID: 36916098
Although platin desensitization is a safe and effective alternative for patients with hypersensitivity reactions (HSRs), sometimes breakthrough reactions (BTRs) can be encountered. However, data about the risk factors for BTRs...
4.
Cetin G, Yilmaz I, Turk M, Arslan B, Nazik Bahcecioglu S
Turk J Med Sci
. 2022 Nov;
52(4):1223-1234.
PMID: 36326412
Background: Venom immunotherapy (VIT) is the most effective treatment method to prevent recurrent systemic reactions to Hymenoptera stings. In this study, the demographic characteristics of VIT patients, the success rates...
5.
Nazik Bahcecioglu S, Turk M, Cetin G, Yilmaz I
Tuberk Toraks
. 2022 Jul;
70(2):141-148.
PMID: 35785878
Introduction: Currently, there are four different diagnostic criteria systems for allergic bronchopulmonary aspergillosis (ABPA): The Rosenberg-Patterson, Seropositive ABPA (ABPA-S), Central Bronchiectasis and ABPA (ABPA-CB), and the International Society for Human...
6.
Vural Solak G, Aksu K, Topel M, Cuhadar Ercelebi D, Yesilkaya S, Demir S, et al.
J Oncol Pharm Pract
. 2022 Jan;
28(6):1454-1457.
PMID: 35060790
Introduction: Osimertinib is an approved therapy for patients with a Thr790met (T790M) mutation diagnosed with non-small cell lung cancer (NSCLC) that progresses during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...
7.
Turk M, Nazik Bahcecioglu S, Yilmaz I
J Allergy Clin Immunol Pract
. 2021 Jun;
9(6):2546.
PMID: 34112491
No abstract available.
8.
Yilmaz I, Nazik Bahcecioglu S, Turk M, Tutar N, Cetin G, Arslan B
Turk J Med Sci
. 2021 May;
51(4):1953-1959.
PMID: 33932968
Background/aim: The efficacy of mepolizumab has been largely demonstrated in clinical trials in patients with severe eosinophilic asthma (SEA). However, reports on experience with mepolizumab in a real-life cohort are...
9.
Cetin G, Turk M, Nazik Bahcecioglu S, Yilmaz I
Eur J Clin Nutr
. 2021 Mar;
75(12):1829-1831.
PMID: 33742157
Total parenteral nutrition (TPN) is a commonly used treatment method for patients whose oral intake is insufficient or who cannot use the gastrointestinal system. In the literature hypersensitivity reactions to...
10.
Turk M, Yilmaz I, Nazik Bahcecioglu S, Can P, Ertas R, Kartal D, et al.
Dermatol Ther
. 2020 Nov;
34(1):e14543.
PMID: 33190334
The question how second-generation antihistamines (sgAHs) should be used when chronic spontaneous urticaria (CSU) is under control with omalizumab is still unanswered. This study aimed to investigate the effectiveness of...